American Vanguard (NYSE:AVD) Announces Quarterly Earnings Results

American Vanguard (NYSE:AVD) issued its quarterly earnings data on Monday. The basic materials company reported ($0.18) earnings per share (EPS) for the quarter, Zacks reports. American Vanguard had a negative net margin of 23.72% and a negative return on equity of 26.21%.

American Vanguard Trading Down 2.4%

AVD stock traded down $0.12 during midday trading on Monday, reaching $4.98. The stock had a trading volume of 69,342 shares, compared to its average volume of 216,818. The business has a fifty day simple moving average of $5.31 and a two-hundred day simple moving average of $4.66. The company has a quick ratio of 1.00, a current ratio of 1.91 and a debt-to-equity ratio of 0.82. The firm has a market cap of $141.59 million, a price-to-earnings ratio of -1.12 and a beta of 1.26. American Vanguard has a twelve month low of $3.28 and a twelve month high of $6.68.

Institutional Investors Weigh In On American Vanguard

Several institutional investors have recently modified their holdings of AVD. Strs Ohio bought a new stake in shares of American Vanguard during the first quarter worth approximately $28,000. XTX Topco Ltd acquired a new stake in American Vanguard during the 2nd quarter worth $57,000. Jane Street Group LLC raised its position in shares of American Vanguard by 287.6% during the 1st quarter. Jane Street Group LLC now owns 40,509 shares of the basic materials company’s stock valued at $178,000 after acquiring an additional 30,058 shares during the last quarter. Acadian Asset Management LLC lifted its stake in shares of American Vanguard by 1,732.4% in the 1st quarter. Acadian Asset Management LLC now owns 58,234 shares of the basic materials company’s stock valued at $253,000 after purchasing an additional 55,056 shares during the period. Finally, Marshall Wace LLP bought a new position in shares of American Vanguard in the 2nd quarter worth $287,000. Institutional investors and hedge funds own 79.00% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on AVD shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of American Vanguard in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of American Vanguard from a “hold” rating to a “buy” rating in a research report on Friday, September 5th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, American Vanguard presently has an average rating of “Hold” and an average price target of $12.00.

American Vanguard Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.